Ivaglom 5 Tablet contains Ivabradine 5mg, a selective sinus node inhibitor used primarily for the management of chronic stable angina pectoris and heart failure. Ivabradine acts by specifically inhibiting the If current in the sinoatrial node, leading to heart rate reduction without affecting myocardial contractility or intracardiac conduction. This heart rate reduction decreases myocardial oxygen demand, thereby alleviating symptoms of angina and improving exercise tolerance. Ivaglom 5 is indicated for patients with stable angina who are intolerant to or inadequately controlled by beta-blockers, as well as for patients with chronic heart failure with reduced ejection fraction (HFrEF) who are in sinus rhythm with a resting heart rate above 70 beats per minute despite optimal standard therapy. It is contraindicated in patients with acute decompensated heart failure, severe hypotension, sinoatrial block, or pacemaker dependence. Common adverse effects include bradycardia, luminous phenomena (phosphenes), and dizziness. Ivaglom 5 should be used with caution in patients with hepatic impairment and those taking other heart rate-lowering agents. Dosage adjustments may be necessary based on clinical response and tolerability. Regular monitoring of heart rate and rhythm is recommended during therapy to ensure safety and efficacy.